The C-type natriuretic peptide/natriuretic peptide receptor-B/cGMP pathway plays an important role in the regulation of endochondral ossification. In chondrocytes, the physiological effect of cGMP is mediated primarily by the activation of cGMP-dependent protein kinase II (cGK-II). In this study, we investigated the transcriptional regulation of cGK-II in chondrocytes. The expression pattern of cGK-II transcripts was examined during chondrogenic differentiation of ATDC5 cells. cGK-II mRNA was not detectable in undifferentiated cells, but increased dramatically prior to differentiation to the hypertrophic stage. To analyze the transcriptional regulation of cGK-II, the 5 0 -flanking region of the mouse cGK-II gene was isolated and characterized. The promoter activity of the cGK-II gene decreased markedly following deletion and mutagenesis of the putative Nkx-binding site between nucleotide positions À292 and À286. These results suggest that the homeobox gene Nkx family is critical for the transcriptional regulation of cGK-II during chondrogenesis.
The C-type natriuretic peptide/natriuretic peptide receptor-B/cGMP pathway plays an important role in the regulation of endochondral ossification. In chondrocytes, the physiological effect of cGMP is mediated primarily by the activation of cGMP-dependent protein kinase II (cGK-II). In this study, we investigated the transcriptional regulation of cGK-II in chondrocytes. The expression pattern of cGK-II transcripts was examined during chondrogenic differentiation of ATDC5 cells. cGK-II mRNA was not detectable in undifferentiated cells, but increased dramatically prior to differentiation to the hypertrophic stage. To analyze the transcriptional regulation of cGK-II, the 5 0 -flanking region of the mouse cGK-II gene was isolated and characterized. The promoter activity of the cGK-II gene decreased markedly following deletion and mutagenesis of the putative Nkx-binding site between nucleotide positions À292 and À286. These results suggest that the homeobox gene Nkx family is critical for the transcriptional regulation of cGK-II during chondrogenesis.
Key words: cGMP; cGMP-dependent protein kinase II (cGK-II); transcriptional regulation; chondrogenesis Endochondral ossification is responsible for the development of the long bones of the limbs, vertebrae, and ribs. In the initial steps of this process, undifferentiated mesenchymal cells condense and differentiate into chondroblasts. These cells then progress through a program of cell proliferation, maturation, and hypertrophy. Hypertrophic chondrocytes, which represent the terminally differentiated phenotype, are finally replaced by bone cells. These events must be properly coordinated, and many hormones and growth factors are known to participate in regulating cartilage formation. 1) C-type natriuretic peptide (CNP) is a peptide hormone that belongs to the family of natriuretic peptides comprising ANP (atrial natriuretic peptide), BNP (brain natriuretic peptide), and CNP. CNP plays an important role in the regulation of endochondral ossification via its binding to natriuretic peptide receptor B (NPR-B). 2) CNP-deficient mice display dwarfism with significantly reduced length of endochondral bones.
3) A similar phenotype has been observed in mice deficient for the NPR-B.
4) The binding of CNP to NPR-B results in elevated intracellular cGMP concentrations. cGMP signaling is primarily mediated by the activation of cGMP-dependent protein kinases (cGKs). 5) Two types of cGKs, cytosolic cGK-I and membrane-bound cGK-II, have been identified in mammals. Previous studies indicate that cGK-II-deficient mice display dwarfism due to impaired endochondral ossification. 6) Furthermore, a loss-of-function mutation in the cGK-II gene in the Komeda miniature rat Ishikawa strain causes dwarfism, 7) indicating that CNP/NPR-B/cGMP signaling functions via cGK-II, but not cGK-I, in chondrocytes. 8) On the growth plate, cGK-II is expressed predominantly in late proliferative and prehypertrophic chondrocytes and promotes their hypertrophic differentiation. 6, 7) A recent report indicated that cGK-II promotes chondrocyte hypertrophy and skeletal growth through phosphorylation and inactivation of glycogen synthase kinase-3, 9) but the transcriptional regulatory mechanism of cGK-II during skeletogenesis remains obscure.
In this study, we focused on the transcriptional regulation of cGK-II in chondrocytes. Promoter analysis revealed the transcriptional mechanism of cGK-II during the cartilage differentiation process.
Materials and Methods
Cell culture. Rat chondrosarcoma (RCS) cells were obtained from Dr. Karen B. King (University of Colorado Denver, Aurora, CO). 10) RCS cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS) and antibiotics (100 IU/ml penicillin and 100 mg/ml streptomycin sulfate). ATDC5 cells were routinely grown in a maintenance medium consisting of DMEM/F12 (1:1) containing 5% FCS, 10 mg/ml human transferrin (Roche Diagnostics, Mannheim, Germany), 3 Â 10 À8 M sodium selenite, and antibiotics. Both cell lines were grown at 37 C under 5% CO 2 . For chondrogenesis, ATDC5 cells were plated at a density of 1 Â 10 5 cells/35-mm dish and were cultured in maintenance medium for 4 d so as to reach confluence. These cells were then incubated in differentiation medium consisting of maintenance medium supplemented with 10 mg/ml of bovine insulin (Sigma-Aldrich, St. Louis, MO) for 27 d with medium changes every third day.
RT-PCR analysis. Total RNA was isolated using Isogen solution (Nippon Gene, Tokyo) according to the manufacturer's protocol. One mg of each total RNA sample was reverse-transcribed with Moloney murine leukemia virus reverse transcriptase using a random hexamer. PCR was carried out through [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (Table 1) . PCR products were subjected to 1.5% agarose gel electrophoresis, and DNA fragments were detected using ethidium bromide staining.
5
0 -RACE analysis of transcription initiation sites. The 5 0 end of mouse cGK-II cDNA was determined by 5 0 -RACE methods using the 5 0 -Full RACE Core Set (Takara Bio, Ohtsu, Japan). First-strand DNA was synthesized from total RNA (3 mg) isolated from differentiated ATDC5 cells using a 5 0 -phosphorylated cGK-II specific primer (5 0 -agggcttcattgctg-3 0 ). The first PCR reaction was carried out using the 1st-primer set (5 0 -tcagtgaagcccaagcatgctaag-3 0 and 5 0 -catttcccatgttgctcagggacc-3 0 ), and the nested PCR reaction was performed using the 2nd-primer set (5 0 -cacccagatggccattcagggaac-3 0 and 5 0 -ggtaactttccaggtgcgcagctc-3 0 ). Amplified products were analyzed by agarose gel electrophoresis, cloned using pGEM-T-easy vector (Promega, Madison, WI) and subsequently sequenced.
Construction of mouse cGK-II reporter plasmids. A 1.5-kb fragment of the mouse cGK-II promoter was amplified from MSM mouse BAC clones (Riken Bioresource Center, Tsukuba, Japan).
11) The amplified PCR product was cloned into pGEM-T-easy vector, and the fidelity of the sequence was confirmed by DNA sequencing. The insert was then cloned into the BglII and HindIII sites of the pGL3-basic luciferase reporter gene vector (Promega), resulting in pGL3-mcGK-II À1508=À1. A series of deletion mutant constructs of the mouse cGK-II promoter were similarly generated. To construct pGL3-TATA and pGL3-TATA-mcGK-II À298=À281, oligonucleotide sets (5 0 -gatctGGGTATATAATGGa-3 0 and 5 0 -agcttCCATTATATACCCa-3 0 for TATA) and (5 0 -gatctTCGCCCTACTTAAGTTGCGGGTATATAATGGa-3 0 and 5 0 -agcttCCATTATATACCCGCAACTTAAGTAGGGCGAa-3 0 for TATA-mcGK-II À291=À281) were annealed. The annealed oligonucleotides were cloned into the BglII and HindIII sites of pGL3-basic.
Luciferase reporter assay. RCS cells were plated at a density of 2:5 Â 10 4 cells in a 24-well plate. After 24 h, the cells were cotransfected with a total of 0.25 mg of promoter construct together with pCMV--galactosidase using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). At 24 h following transfection, the cells were lysed and subjected to luciferase reporter assay. -Galactosidase and luciferase assays were performed as previously described.
12) -Galactosidase activity was measured to normalize luciferase activity.
Results

Expression patterns of cGK-II during the chondrogenesis of ATDC5 cells
Mouse embryonal carcinoma-derived cell line ATDC5 cells, used as a model for chondrogenesis, initiate chondrogenic differentiation in confluent cultures exposed to insulin. 13) Using this model cell, the expression patterns of cGK-II during chondrogenic differentiation were investigated. Confluent ATDC5 cells were treated with 10 mg/ml insulin (day 0), after which cells were collected at various time points for RT-PCR analysis. As shown in Fig. 1A , expression of type II collagen, a marker of early and mature chondrocytes, was detected at day 9 and peaked at day 15, whereas the transcript level of the hypertrophic chondrocyte marker type X collagen began to increase at day 15. cGK-II transcripts were not detected in undifferentiated ATDC5 cells, but they gradually increased during differentiation and reached a plateau at day 15, as did type II collagen, indicating that cGK-II was predominantly expressed in mature chondrocytes. The expression pattern of cGK-II during ATDC5 differentiation was identical to that observed in mouse growth plate cartilage.
6,7) By comparison, CNP mRNA increased progressively until day 15 and declined thereafter, while the level of NPR-B mRNA remained relatively unchanged.
The expression of cGK-II in rat chondrosarcoma (RCS) cells was also examined. RCS cells show the characteristics of pre-expansion cartilage cells and express type II collagen, but not type X collagen. 10, 14) The expression level of cGK-II transcripts was higher in RCS cells than in ATDC5 at day 18 (Fig. 1B) . RCS cells were used to investigate the regulatory mechanisms underlying cGK-II expression in chondrocytes because of the low transfection efficiency of differentiated ATDC5 cells. 
Analysis of cGK-II promoter activity in RCS cells
To elucidate a mechanism for the regulation of cGK-II gene expression in chondrocytes, the transcription initiation site of the mouse cGK-II gene was determined by 5 0 -RACE using cDNA prepared from mRNA isolated from differentiated ATDC5 cells at day 18. 5 0 RACE analysis revealed that a single transcription initiation site of the mouse cGK-II gene was located at the guanosine (designated as þ1) 208 nucleotides upstream of the translation start codon ATG (Fig. 2) . The first exon includes only the 5 0 untranslated region, while the ATG start codon is located in exon 2, which is approximately 12 kb downstream of exon 1. Based on this result, the approximately 1.5-kb 5 0 -flanking region of the mouse cGK-II gene was cloned from the mouse BAC clone. Nucleotide sequence analysis demonstrated that this region was 71% identical to that of the published human cGK-II gene. 15) Furthermore, a search of transcription factor binding sites done using the TFSEARCH program (http://www.cbrc.jp/research/db/ TFSEARCH.html) showed that the mouse cGK-II promoter contained multiple putative recognition motifs for various transcription factors, including Runx, Sox, Nkx, and Sp1.
To analyze cGK-II promoter activity in the chondrocytes, the 5 0 -flanking region of the mouse cGK-II gene was inserted in luciferase reporter vector pGL3-basic, generating pGL3-mcGK-II À1508=À1. This construct was introduced into RCS cells, and the cell lysates were assayed for luciferase activity. As shown in Fig. 3A , the 1.5-kb promoter region (À1508=À1) exhibited 6-fold higher promoter activity than promoterless pGL3-basic. To determine the elements involved in the promoter functions in chondrocytes, a series of deletion constructs of the cGK-II promoter were generated and used in luciferase reporter assay. The level of promoter activity of À650=À1 was almost the same as that of the À1508=À1. The À330=À1 promoter construct showed a higher level of luciferase activity than À650=À1, suggesting the presence of negative regulatory elements in the promoter region from À650 to À330. Interestingly, a deletion from À330 to À232 resulted in a marked decrease in luciferase activity, indicating that the strong transactivating elements are located between À330 and À232. Additionally, the À107=À1 construct exhibited no transcriptional activity. The region between À232 and À107 contains a consensus Sp1 site, suggesting that Sp1 plays a role in the basal activity of the cGK-II promoter.
To define the minimal transactivating element sufficient for cGK-II promoter-driven gene transcriptional activity, shorter deletion constructs were created and assayed by luciferase assay. As shown in Fig. 3B , a higher level of luciferase activity was detected with À330=À1 and À298=À1. In contrast, À281=À1 and À265=À1 did not significantly increase transcriptional activity above that of À232=À1, indicating that the 18 base pairs of nucleotides from À298 to À281 contain sequences essential for cGK-II promoter-driven transcriptional activity in RCS cells. The promoter activity of the cGK-II gene in undifferentiated ATDC5 cells was also determined. The luciferase activity in undifferentiated ATDC5 cells was unchanged by deletion, and was lower than that in RCS cells, suggesting that this region specifically functions in differentiated chondrocytes. Furthermore, the minimal reporter construct pGL3- TATA-mcGK-II À298=À281 (À298=À281 TATA), which contains the region from À298 to À281 of the mouse cGK-II gene and a TATA box, was produced, and the promoter activity in the RCS cells was examined. As shown in Fig. 3C , the promoter activity of À298=À281 TATA increased significantly (approximately 2.3-fold) as compared to that of pGL3-basic, but this increase was much smaller.
The DNA sequence (TCGCCCTACTTAAGTTGC, putative Nkx-binding site underlined) from À298 to À281 of the mouse cGK-II gene is entirely identical to that of the human gene, 15) and contains a putative Nkxbinding site ((C/T)ACTTAA). 16) To determine whether the Nkx-binding site is functional in the regulation of cGK-II gene expression in RCS cells, four mutants of À298=À1 were constructed and used in luciferase reporter assay (Fig. 4) . The reporter activities of MT2 (TCGCCCatggTAAGTTGC, mutations indicated by lower-case letters) and MT3 (TCGCCCTACTggc-GTTGC), which are mutated in the putative Nkxbinding site (TACTTAA), decreased dramatically, to the level of that of À281=À1. By comparison, MT1 (TCGaggTACTTAAGTTGC) and MT4 (TCGCCCTACTTAAaggcC) were nearly the same as the wild type. A site-directed mutagenesis experiment indicated that the potential Nkx-binding site from À298 to À281 contributed to the promoter activity of cGK-II in the chondrocytes.
Discussion
cGK-II plays an important role in regulating chondrogenic differentiation. Previous reports indicate that cGK-II is expressed predominantly in late proliferative and prehypertrophic chondrocytes in the growth plate cartilage and act as a molecular switch from proliferation to hypertrophic differentiation stages of chondrocytes.
7) The present results also indicate that cGK-II is predominantly expressed in mature chondrocytes, but not in undifferentiated cells. These observations suggest that appropriate expression of cGK-II during differ- Site-directed mutants of the pGL3-mcGK-II À298=À1 were generated. The wild-type and mutant constructs were transfected into RCS cells. Luciferase activity was expressed relative to the luciferase activity of pGL3-basic and normalized to -galactosidase activity. Data represent the mean AE S.D. of at least three independent experiments.
entiation is a critical factor in its function. A recent study reported that expression of cGK-II in chondrocytes was stimulated by a synthetic glucocorticoid, dexamethasone, 17) but the detailed mechanisms regulating cGK-II expression during cartilage development are unknown. Here, we carried out a series of experiments to clone and characterize the 5 0 -flanking region of the mouse cGK-II gene. Deletion and site-directed mutagenesis analyses demonstrated that the region from À298 to À281 was critical for the transcriptional activation of the mouse cGK-II gene in mature chondrocytes. The approximately 1.5-kb 5 0 -flanking region of the mouse cGK-II gene contains multiple Sox consensus binding sites. Sox9, a member of the Sox family, has been found to regulate chondrogenesis. 18) Sox9 is required for the commitment of chondrogenic cell lineage, mesenchymal condensation, and chondrocyte proliferation, differentiation, maturation and hypertrophic conversion. For example, Sox9 activates expression of type II collagen, a major cartilage matrix protein. 19) Type II collagen has an expression pattern similar to that of cGK-II during the chondrogenic differentiation of ATDC5 cells, suggesting that the cGK-II gene may be also transcriptionally regulated by Sox9. However, the putative Sox binding sites were not necessary for chondrocyte-specific expression of the cGK-II gene. Furthermore, forced expression of Sox9 did not activate cGK-II promoter activity (data not shown). On the other hand, a previous study showed that cGK-II caused attenuation of Sox9 transcriptional function through inhibition of nuclear entry in chondrocytes. 7) The nucleotide sequence from À298 to À281 (TCGC-CCTACTTAAGTTGC) contains a putative Nkx-binding site ((C/T)ACTTAA). Interestingly, this nucleotide sequence is completely conserved in both position and sequence between mouse and human cGK-II promoter sequences, 15) suggesting that the human cGK-II gene is also transcriptionally activated through this region during chondrogenic differentiation. Nkx is a family of homeobox genes that has a critical role in cell differentiation. For example, Nkx2.5 is highly expressed in the heart and is essential for cardiac development. 20) Nkx2.5 binds to a specific consensus DNA sequence, T(C/T)AAGTG, and functions as a transcriptional activator. In contrast, Nkx3.2 is a negative regulator during chondrogenesis. 21) Nkx3.2 binds directly to the Runx2 promoter (CACTTT) and promotes chondrogenic differentiation via repression of Runx2 transcription, but no transactivating member of the Nkx family involved in chondrogenesis has been identified. Distal-less homeobox (Dlx) genes also regulate chondrogenesis. 22) Dlx2 is involved in BMP2-mediated induction of chondroblast differentiation and type II collagen expression.
23) The putative Nkx-binding site identified in the cGK-II gene promoter (TACTTAA) differs in only one nucleotide (underlined) from the consensus Dlx recognition sequence (TAATT). Hence, we examined to determine whether Dlx2 transactivates the mouse cGK-II gene promoter by luciferase reporter assay. However, Dlx2 had no effect on cGK-II promoter activity (data not shown). On the other hand, Nkx and Dlx have been shown to regulate gene expression through cooperative interaction with other DNA-binding proteins, such as GATA and Sp1. 24, 25) Taken together with the drastic decrease in reporter activity caused by deletion from À232 to À107 (Fig. 3A) and the relatively low reporter activity of À298=À281 TATA (Fig. 3C) , other ciselements might be involved in the regulation of cGK-II expression in cooperation with the region from À298 to À281. In summary, we characterized the promoter region of the cGK-II gene in mature chondrocytes, and a putative Nkx-binding site was identified as an essential cis-acting element in the transcriptional activation of the cGK-II gene. However, we have not identified the specific factor(s) that bind to this site. Further investigation is required to determine the transcriptional regulation of the cGK-II gene. These findings should provide a better understanding the functions of cGK-II in cartilage formation.
